U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 091616
Company: GLENMARK PHARMS LTD
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
LITHIUM CARBONATE LITHIUM CARBONATE 450MG TABLET, EXTENDED RELEASE;ORAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
02/14/2011 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
10/13/2022 SUPPL-12 Labeling-Patient Package Insert, Labeling-Package Insert

Label is not available on this site.

02/05/2020 SUPPL-9 Labeling-Package Insert

Label is not available on this site.

12/20/2018 SUPPL-8 Labeling-Package Insert

Label is not available on this site.

12/07/2018 SUPPL-7 Labeling-Package Insert

Label is not available on this site.

LITHIUM CARBONATE

TABLET, EXTENDED RELEASE;ORAL; 450MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
LITHIUM CARBONATE LITHIUM CARBONATE 450MG TABLET, EXTENDED RELEASE;ORAL Prescription No AB 091616 GLENMARK PHARMS LTD
LITHIUM CARBONATE LITHIUM CARBONATE 450MG TABLET, EXTENDED RELEASE;ORAL Prescription No AB 076691 HIKMA
LITHIUM CARBONATE LITHIUM CARBONATE 450MG TABLET, EXTENDED RELEASE;ORAL Prescription No AB 202219 MYLAN PHARMS INC
LITHIUM CARBONATE LITHIUM CARBONATE 450MG TABLET, EXTENDED RELEASE;ORAL Prescription No AB 205663 UNIQUE
Back to Top